Electrochemical simulation of psychotropic drug metabolism compared to in vivo processes using liquid chromatography and mass spectrometry
Elektrochemische Simulation des Metabolismus psychotroper Arzneimittel im Vergleich zu in-vivo-Prozessen mittels Flüssigchromatographie und Massenspektrometrie
Frontiers in Pharmacology · 28.08.2025 · 16
DOI: 10.3389/fphar.2025.1637852 ↗Auf einen Blick
Untersucht wurde, wie gut elektrochemische Oxidation und Lebermikrosomen die Metaboliten psychotroper Arzneimittel nachbilden. Die in-vivo-Daten stimmten mit der elektrochemischen Oxidation überein.
Fragestellung
Wie gut simulieren elektrochemische Verfahren den oxidativen Metabolismus ausgewählter psychotroper Arzneimittel im Vergleich zu Lebermikrosomen und Humanproben?
Methode
Elektrochemische Oxidation in einer Dünnschichtzelle mit bor-dotierter Diamantelektrode; zusätzlich Lebermikrosomen und LC-MS/MS-Analyse von Humanplasma.
Ergebnisse
Die in-vivo-Experimente stimmten mit den Daten der elektrochemischen Oxidation überein. Einige potenzielle Metaboliten wurden durch die elektrochemische Oxidation und in Lebermikrosomen vorhergesagt.
Schlussfolgerung der Autor:innen
EC-(LC)-MS eignet sich zur Simulation des oxidativen Metabolismus ausgewählter psychotroper Arzneimittel und liefert orthogonale Informationen zu Metaboliten.
Kernaussagen
- In-vivo-Daten und elektrochemische Oxidation stimmten überein
- Einige Metaboliten wurden durch EC und Lebermikrosomen vorhergesagt
- EC-(LC)-MS kann reaktive Transformationsprodukte direkt identifizieren
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 28.08.2025. Verfasst von Paulina Jerszyńska und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Chemistry and Bioanalytics, Faculty of Chemistry, Nicolaus Copernicus University, Torun, Poland. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uniwersytet Mikolaja Kopernika w Toruniu.
Abstract (Originalsprache)
Introduction
Psychotropic drugs strongly affect the human psyche through their ability to modulate the neurotransmitter activity and to treat mental disorders and diseases. Monitoring of psychotropic drugs in clinical studies is significant. Thus. establishing methodologies for analyzing these drugs and their pharmacologically active metabolites in biological matrices is essential for patients’ safety. Therefore, therapeutic drug monitoring (TDM) of these drugs in patients receiving pharmacotherapy in psychiatric hospitals is necessary to avoid medical complications, psychiatric adverse effects, or poisoning. In addition to TDM, the main factor in pharmacokinetics that should be monitored along with the drug is its metabolic pathway. The literature on transformation products (TPs) resulting from the psychotropic drug degradation is limited. Hence, to investigate the potential TPs of target compounds, electrochemistry (EC) and liver microsome assays were used to generate TPs, which were further characterized using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The results obtained by EC-(LC)-MS and liver microsome assays were compared with conventional in vivo studies by analyzing biological samples (human plasma) from patients.
Methods
The electrochemical mimicry of the oxidative phase I and II metabolism was achieved in a thin-layer cell equipped with a boron-doped diamond (BDD) working electrode under controlled potential conditions. Structures were proposed for the electrochemically generated products based on the MS/MS experiments. Moreover, in order to examine the proposed metabolic pathways of target compounds, the incubation with human liver microsomes was applied. Additionally, a sensitive, specific, and rapid LC-MS/MS method was developed and validated to quantify selected drugs and their metabolites in biological samples. The preparation of biological samples was accomplished through microextraction by a packed sorbent (MEPS). Finally, the results from LC-MS/MS analysis of biological samples, liver microsomes and electrochemical TPs were compared to evaluate the quality of electrochemical metabolism mimicry. Results and discussion Data from in vivo experiments agreed with the data from electrochemical oxidation, which predicted some of the potential metabolites found in the human liver microsomes. EC–(LC)-MS is well-suited for the simulation of the oxidative metabolism of selected psychotropic drugs and acts as the orthogonal source of information about drug metabolites compared to liver microsomes and biological matrices. EC-(LC)-MS enables the direct identification of reactive TPs, circumvents time-consuming sample preparation and is ethically advantageous because it reduces the need for animal experiments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Environmental Chemistry and Bioanalytics, Faculty of Chemistry, Nicolaus Copernicus University, Torun, Poland.
- Centre for Modern Interdisciplinary Technologies, Nicolaus Copernicus University, Torun, Poland.
Förderung
- Uniwersytet Mikolaja Kopernika w Toruniu
Zitieren
APA
Jerszyńska, P., & Szultka-Młyńska, M. (2025). Electrochemical simulation of psychotropic drug metabolism compared to in vivo processes using liquid chromatography and mass spectrometry. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1637852
Vancouver
Jerszyńska P, Szultka-Młyńska M. Electrochemical simulation of psychotropic drug metabolism compared to in vivo processes using liquid chromatography and mass spectrometry. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1637852
BibTeX
@article{Jerszyska2025,
author = {Jerszyńska, Paulina and Szultka-Młyńska, Małgorzata},
title = {Electrochemical simulation of psychotropic drug metabolism compared to in vivo processes using liquid chromatography and mass spectrometry},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1637852}
}
EUVIMED